BeOne Medicines Ltd. 8-K

What Happened
BeOne Medicines Ltd. (ticker: ONC) announced its financial results for the three months and the year ended December 31, 2025 in a press release issued February 26, 2026. The company filed those results on Form 8-K (Item 2.02); the press release is attached as Exhibit 99.1 to the filing and highlights the global success of BRUKINSA and the company’s foundational oncology leadership.

Key Details

• Announcement date: February 26, 2026 (Form 8-K filed same day).
• Reporting periods: the three months and the year ended December 31, 2025.
• Press release attached as Exhibit 99.1 titled “BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership.”
• Form references: Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Exhibits).

Why It Matters
Earnings releases update investors on recent revenue, operating results and commercial progress; BeOne’s release specifically calls out BRUKINSA’s global performance, which may be a key driver of near‑term sales and strategy. This 8‑K does not itself list detailed financial line items in the filing text — investors should read the attached press release (Exhibit 99.1) for the full metrics and consider the results in the context of prior quarters and guidance.